The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996. 1996

S O'Reilly, and E K Rowinsky
Division of Medical Oncology, Johns Hopkins Oncology Center, Baltimore, Maryland 21287-8934, USA.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077146 Irinotecan A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin,CPT 11,CPT-11,Camptosar,Camptothecin-11,Irinotecan Hydrochloride,Irrinotecan,NK012 Compound,SN 38,SN 38 11,SN-38,SN-38-11,7 Ethyl 10 hydroxycamptothecin,CPT11,Camptothecin 11,SN3811
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics

Related Publications

S O'Reilly, and E K Rowinsky
January 2005, Drug metabolism reviews,
S O'Reilly, and E K Rowinsky
February 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
S O'Reilly, and E K Rowinsky
March 1990, Cancer research,
S O'Reilly, and E K Rowinsky
September 1996, Critical reviews in oncology/hematology,
S O'Reilly, and E K Rowinsky
April 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
S O'Reilly, and E K Rowinsky
January 1997, American journal of therapeutics,
S O'Reilly, and E K Rowinsky
August 2001, Clinical cancer research : an official journal of the American Association for Cancer Research,
S O'Reilly, and E K Rowinsky
January 1996, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!